David Wyles
- Hepatology top 0.2%
- Epidemiology top 1%
- Infectious Diseases top 2%
- Molecular Biology
- Cardiology and Cardiovascular Medicine
- Co-authors
- Thomas HermannRobert T. SchooleyEdward R. CachayMark SulkowskiSergey M. DibrovAnne F. LuetkemeyerJerod ParsonsJohn G. McHutchison
- Topics
- Hepatitis C virus research (95 papers)HIV/AIDS drug development and treatment (48 papers)Liver Disease Diagnosis and Treatment (36 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
David Wyles
106 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 94
- Hepatology 2.0k
- Epidemiology 1.7k
- Infectious Diseases 865
- Molecular Biology 396
- Cardiology and Cardiovascular Medicine 140
Countries citing papers authored by David Wyles
This map shows the geographic impact of David Wyles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wyles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wyles more than expected).
Fields of papers citing papers by David Wyles
This network shows the impact of papers produced by David Wyles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wyles. The network helps show where David Wyles may publish in the future.
Co-authorship network of co-authors of David Wyles
This figure shows the co-authorship network connecting the top 25 collaborators of David Wyles. A scholar is included among the top collaborators of David Wyles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wyles. David Wyles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 29 | |
| 5 | 22 | |
| 6 | 72 | |
| 7 | Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection | 4 |
| 8 | 3 | |
| 9 | 58 | |
| 10 | 160 | |
| 11 | 17 | |
| 12 | 68 | |
| 13 | 39 | |
| 14 | 12 | |
| 15 | 52 | |
| 16 | 1 | |
| 17 | 13 | |
| 18 | 4 | |
| 19 | 132 | |
| 20 | 14 |
About David Wyles
David Wyles is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 110 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (95 papers), HIV/AIDS drug development and treatment (48 papers) and Liver Disease Diagnosis and Treatment (36 papers). The work is most often cited by research in Hepatology (2.0k citations), Epidemiology (1.7k citations) and Infectious Diseases (865 citations). David Wyles has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Thomas Hermann, Robert T. Schooley, Edward R. Cachay, Mark Sulkowski, Sergey M. Dibrov, Anne F. Luetkemeyer, Jerod Parsons, John G. McHutchison, Kelly A. Kaihara and Eva Poveda. Their work appears in journals such as Proceedings of the National Academy of Sciences, Annals of Internal Medicine and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.